NCT01748006

Brief Summary

The relationship between the activation of the vasopressin system and central hemodynamics in heart failure (including right and left heart filling pressures and cardiac output) is not clear. The investigators intend to examine the correlation between levels of copeptin and vasopressin and the central hemodynamic system in patients with advanced (class III or IV) heart failure. The investigators also aim to examine the relationship of selected cardiac biomarkers in blood and urine with cardiac filling pressures and cardiac output in patients with decompensated heart failure. The study population will consist of 30 patients admitted to the Department of Cardiology at Copenhagen University Hospital. Only patients for whom the attending cardiologist has already decided upon right heart catheterization for clinical/treatment reasons will be recruited for the study.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jun 2012

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2012

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

August 15, 2012

Completed
4 months until next milestone

First Posted

Study publicly available on registry

December 12, 2012

Completed
3.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2016

Completed
Last Updated

October 28, 2015

Status Verified

October 1, 2015

Enrollment Period

4 years

First QC Date

August 15, 2012

Last Update Submit

October 26, 2015

Conditions

Outcome Measures

Primary Outcomes (1)

  • The correlation between levels of plasma copeptin and vasopressin with left ventricular filling pressure and cardiac output

    Day 1

Secondary Outcomes (3)

  • The correlation between levels of plasma copeptin and vasopressin with urine aquaporin-2 concentration

    Day 1

  • The correlation between New York Heart Association (NYHA) class and levels of plasma copeptin and vasopressin

    Day 1

  • The correlation between biomarkers levels and survival free of transplantation- and left ventricular assist device insertion

    1 year

Study Arms (1)

Blood and urine samples

Other: Standard of care therapy for severe decompensated heart failure

Interventions

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population will consist of 30 patients with heart failure admitted to the Department of Cardiology at the Copenhagen University Hospital, Rigshospitalet,Dennmark. Only patients who are already referred to right heart catheterization by the attending cardiologist will be recruited for the study.

You may qualify if:

  • Age \> 18 years
  • Left ventricular ejection fraction \< 40 %
  • Diagnosed symptomatic heart failure treated with heart failure medications for at least 30 days.
  • Clinical indication for right heart catheterization for clinical/treatment reasons
  • NYHA-class III-IV
  • Relevant heart failure treatment as tolerated by the patient

You may not qualify if:

  • Absence of clinical/treatment indication of right heart catheterization
  • Syndrome of Inappropriate Secretion of ADH (SIADH)
  • Recent acute myocardial infarction within the last 30 days
  • Presence of infection or inflammatory disease
  • Malignant disease
  • Pregnancy
  • Subjects unwilling or unable to provide written consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Cardiology, Copenhagen University Hospital, Rigshospitalet

Copenhagen, Denmark

RECRUITING

Related Publications (1)

  • Balling L, Goetze JP, Jung MH, Rossing K, Boesgaard S, Gustafsson F. Copeptin levels and invasive hemodynamics in patients with advanced heart failure. Biomark Med. 2018 Aug;12(8):861-870. doi: 10.2217/bmm-2017-0439. Epub 2018 Jul 30.

Biospecimen

Retention: SAMPLES WITHOUT DNA

Blood and urine analyses

MeSH Terms

Conditions

Heart Failure

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular Diseases

Study Officials

  • Finn Gustafsson, MD, DMSc

    Rigshospitalet, Denmark

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Finn Gustafsson, MD, DMSc

CONTACT

Louise Balling, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
MD, DMSc

Study Record Dates

First Submitted

August 15, 2012

First Posted

December 12, 2012

Study Start

June 1, 2012

Primary Completion

June 1, 2016

Study Completion

June 1, 2016

Last Updated

October 28, 2015

Record last verified: 2015-10

Locations